Biotech Fades-Amgen Pops on Earnings…Update-3 CPI and Bullard create a big sell-off
At close 2/11: Another crappy day now with Ukraine Crisis coming to fore. But some large cap biopharmas get green: BMY. GILD, REGN up 3.27%, and PFE. Nibbled on NeuroCrine (NBIX) at $85. Update-3 2/11 12p EST...Small caps fight the headwinds but "hold the fort" in early trading. FED officials...
La Nina Snow Drought to continue for West Coast? Update-1…colder and dry
FEB 19 Update : Head North to Montana see below Conditions improving with more snow on the way. Big Sky. Colder week in CA, serious drought continues through FEB. watch San Francisco for weather changes. Long term climate story : Facing the effects of climate change, skiers want to save their...
Healthcare Portfolio Performance January 2022…Updates-2…2/5/22
Update-2 Another Roller Coaster Week helped by AMZN earnings and jobs report.. Healthcare SPDR Sector (XLV) up 1.39% for week, (4.19%) YTD; IBB up 2.08% for week, (14.4%) YTD; XBI up 2.49% for week, (18.9%) YTD. Large cap healthcare stock leaders over 52 weeks: UNH, ABBV, GSK, VRTX. Sector...
Small Cap Biotech Stocks: Is it time to start trading? Update-2 Trading Ideas
Update-2 Feb 6 After a little pop up on Friday we have identified a few trades on technicals. We noticed on screening small cap biotechs that about 90% are at the bottom of their 52 week range. From ARKG holdings two trades and former high fliers: PACB and TDOC. Also have a look at...
What’s next for Biotech Stocks…Update-3 Rally !
Update-1 AAPL ignited rally? Either by oversold conditions or good earnings by AAPL and MSFT we have lift -off from the bottom. If your speculative biotech stocks did not go up today you may want to dump it. Our mid-cap focus list saw nice gains except for CRSP. ARKG was up 4.52% and the XBI...